Supplier News

Feb 23, 2018
By BioPharm International Editors
The contract development and manufacturing organization has entered it first manufacturing contract worth $148 million for its recently completed Plant 3 facility.
Feb 22, 2018
By BioPharm International Editors
The research partnership will focus on advancing regenerative medicine using porcine bioproducts.
Feb 22, 2018
By BioPharm International Editors
Avid Bioservices will provide commercial manufacture of an enzyme replacement therapy by Roivant Sciences' Enzyvant subsidiary.
Feb 22, 2018
By BioPharm International Editors
The company aims to add the additional analytical services in the European Union throughout 2018.
Feb 21, 2018
By BioPharm International Editors
The companies have partnered to develop and commercialize vectorized antibodies against tau for Alzheimer's and other neurodegenerative diseases.
Feb 20, 2018
By BioPharm International Editors
The company has entered into an agreement with an undisclosed partner to support the development and manufacture of a new biomanufacturing cell line.
Feb 16, 2018
By BioPharm International Editors
The company has expanded its single-use manufacturing capabilities at its facility in Fermoy, Ireland.
Feb 14, 2018
By BioPharm International Editors
Ompi EZ-fill vials and Daikyo Seiko PLASCAP press-fit closures are a confirmed product set for use with Vanrx Pharmasystems' Aseptic Filling Workcells.
Feb 14, 2018
By BioPharm International Editors
The companies will work together on developing regenerative medicine therapies for heart failure.
Feb 13, 2018
By BioPharm International Editors
A $800-million acquisition of MPI Research expands Charles River's offerings for early-stage contract research.
native1_300x100
lorem ipsum